质瘤瘤微环境和免疫疗法:过去,现在和未来
Josip Cvitković1, Wen-Lu Tan1, Tao Jiang2,3,4,5
1Beijing Neurosurgical Institute, Capital Medical University, Beijing, 100070, China.
Biomarker research
|November 22, 2025
概括
尽管大脑的免疫环境面临挑战,但新的质瘤免疫疗法正在出现. 将免疫检查点抑制剂与其他治疗方法结合起来,有望改善脑瘤的结果.
科学领域:
- 神经瘤学神经瘤学
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 质瘤是原发性脑瘤,预后不佳,治疗选择有限.
- 免疫疗法,如免疫检查点抑制剂 (ICI),由于免疫抑制瘤微环境 (TME) 和大脑免疫力,在质瘤中表现出适度的疗效.
- 了解质瘤免疫生物学对于开发有效的治疗方法至关重要.
研究的目的:
- 审查最近在质瘤免疫生物学和免疫治疗方面的进展.
- 突出临床试验和新的结合治疗质瘤治疗策略.
- 讨论克服免疫抑制性质瘤TME的方法.
主要方法:
- 关于质瘤免疫生物学和免疫治疗的综合文献综述.
- 对当前临床试验和新兴治疗策略的分析.
- 专注于将ICI与放射治疗和化疗相结合.
主要成果:
- 目前用于质瘤的免疫疗法的有限疗效归因于TME.
- 组合策略旨在重塑TME并增强免疫反应.
- 放射治疗和化疗正在探索,以提高ICI的有效性.
结论:
- 需要创新的策略来增强质瘤免疫疗法.
- 结合ICI和其他方式,有可能改善患者的治疗结果.
- 质瘤免疫疗法的不断发展的景观为更好的治疗提供了希望.
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K


